» Authors » Ignacio Ruz-Caracuel

Ignacio Ruz-Caracuel

Explore the profile of Ignacio Ruz-Caracuel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 49
Citations 223
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Rodriguez-Villena A, Veliz-Dominguez A, Gonzalez-Garcia I, Ruz-Caracuel I
Rev Esp Patol . 2024 Apr; 57(2):151-155. PMID: 38599738
Adenocarcinoma with enteroblastic differentiation is a rare histologic subtype of adenocarcinoma of the gastrointestinal tract that shows unique histologic and immunohistochemical features that resemble fetal intestinal epithelium. This histological subtype...
12.
Martinez-Hernandez R, Serrano-Somavilla A, Fernandez-Contreras R, Sanchez-Guerrero C, Sanchez de la Blanca N, Sacristan-Gomez P, et al.
Mod Pathol . 2024 Mar; 37(5):100475. PMID: 38508520
Pituitary neuroendocrine tumors (PitNETs) account for approximately 15% of all intracranial neoplasms. Although they usually appear to be benign, some tumors display worse behavior, displaying rapid growth, invasion, refractoriness to...
13.
Araujo-Castro M, Biagetti B, Torre E, Novoa-Testa I, Cordido F, Corrales E, et al.
J Clin Endocrinol Metab . 2024 Mar; 109(12):e2178-e2187. PMID: 38436926
Context: Few data exist about the clinical course of acromegaly, surgical and medical outcomes in patients with GH- and prolactin cosecreting pituitary adenomas (GH&PRL-PAs). Nevertheless, some series described a more...
14.
San-Roman-Gil M, Martinez-Delfrade I, Albarran-Fernandez V, Guerrero-Serrano P, Pozas-Perez J, Chamorro-Perez J, et al.
Front Immunol . 2024 Feb; 15:1352262. PMID: 38361927
Immunotherapy has demonstrated a role in the therapeutic landscape of a small subset of patients with colorectal carcinoma (CRC) that harbor a microsatellite instability (MSI-H) status due to a deficient...
15.
Minguez Ojeda C, Gomez Dos Santos V, Alvaro Lorca J, Ruz-Caracuel I, Pian H, Sanjuanbenito Dehesa A, et al.
Ann Endocrinol (Paris) . 2024 Feb; 85(2):104-109. PMID: 38342223
Purpose: To analyze surgical outcomes and predictive factors for long-term overall and disease-specific survival in patients undergoing surgical resection of adrenal metastasis. Methods: A multicenter retrospective study included patients who...
16.
Yilmaz O, Westerhoff M, Panarelli N, Hart J, Groisman G, Ruz-Caracuel I, et al.
Am J Surg Pathol . 2023 Dec; 48(1):70-79. PMID: 38054635
Distinguishing colon carcinoma that is surrounded by well-circumscribed lymphoid tissue from adenomas involving lymphoglandular complexes can be difficult. We assessed a multi-institutional international cohort of 20 colorectal carcinomas with associated...
17.
Minguez Ojeda C, Gomez Dos Santos V, Alvaro Lorca J, Ruz-Caracuel I, Pian H, Sanjuanbenito Dehesa A, et al.
Endocrinol Diabetes Nutr (Engl Ed) . 2023 Nov; 70(9):564-571. PMID: 37996201
Objective: To evaluate the impact of obesity and overweight on surgical outcomes in a large cohort of patients who underwent adrenalectomy due to benign or malignant primary adrenal disease. Methods:...
18.
Mendiola M, Heredia-Soto V, Ruz-Caracuel I, Baillo A, Ramon-Patino J, Escudero F, et al.
Int J Mol Sci . 2023 Oct; 24(19). PMID: 37833916
Approximately 20-30% of endometrial carcinomas (EC) are characterized by mismatch repair (MMR) deficiency (dMMR) or microsatellite instability (MSI), and their testing has become part of the routine diagnosis. The aim...
19.
Gomez-Ramirez J, Luengo P, Mercader E, Quintana A, Munoz de Nova J, Febrero B, et al.
Br J Surg . 2023 Jun; 110(8):1011-1012. PMID: 37343053
No abstract available.
20.
Jungen S, Noti L, Christe L, Galvan J, Zlobec I, Muller M, et al.
Front Med (Lausanne) . 2023 Apr; 10:1110529. PMID: 37035329
Introduction: Over the years, the molecular classification of endometrial carcinoma has evolved significantly. Both POLEmut and MMRdef cases share tumor biological similarities like high tumor mutational burden and induce strong...